Publicaciones en las que colabora con Milagros Balbín Felechosa (14)

2022

  1. Classification of follicular-patterned thyroid lesions using a minimal set of epigenetic biomarkers

    European journal of endocrinology, Vol. 187, Núm. 3, pp. 335-347

2019

  1. Chromatin regulation by Histone H4 acetylation at Lysine 16 during cell death and differentiation in the myeloid compartment

    Nucleic Acids Research, Vol. 47, Núm. 10, pp. 5016-5037

  2. Clinical significance and peculiarities of succinate dehydrogenase B and hypoxia inducible factor 1α expression in parasympathetic versus sympathetic paragangliomas

    Head and Neck, Vol. 41, Núm. 1, pp. 79-91

2018

  1. TP53 p.R72P genotype is a marker of poor prognosis in lung cancer

    Cancer Biomarkers, Vol. 21, Núm. 4, pp. 747-754

2017

  1. Role of VHL, HIF1A and SDH on the expression of miR-210: Implications for tumoral pseudo-hypoxic fate

    Oncotarget, Vol. 8, Núm. 4, pp. 6700-6717

2016

  1. Impact of PI3K/AKT/mTOR pathway activation on the prognosis of patients with head and neck squamous cell carcinomas

    Oncotarget, Vol. 7, Núm. 20, pp. 29780-29793

2013

  1. EGFR l858R mutation may go undetected because of P848l in cis mutation

    Journal of Clinical Oncology, Vol. 31, Núm. 26

  2. Identification of somatic VHL gene mutations in sporadic head and neck paragangliomas in association with activation of the HIF-1αmiR-210 signaling pathway

    Journal of Clinical Endocrinology and Metabolism, Vol. 98, Núm. 10

  3. Matrix metalloproteinase Mmp-1a is dispensable for normal growth and fertility in mice and promotes lung cancer progression by modulating inflammatory responses

    Journal of Biological Chemistry, Vol. 288, Núm. 20, pp. 14647-14656

  4. Medullary thyroid carcinoma and 2q37 deletion in a patient with nevoid basal cell carcinoma syndrome: Clinical description and genetic analysis

    Head and Neck, Vol. 35, Núm. 5

2012

  1. EGFR status and KRAS/BRAF mutations in intestinal-type sinonasal adenocarcinomas

    Cellular Oncology, Vol. 35, Núm. 6, pp. 443-450

  2. Identification of a signaling Axis HIF-1α/MicroRNA-210/ISCU independent of SDH mutation that defines a subgroup of head and neck paragangliomas

    Journal of Clinical Endocrinology and Metabolism, Vol. 97, Núm. 11

2010

  1. Relevance of germline mutation screening in both familial and sporadic head and neck paraganglioma for early diagnosis and clinical management

    Cellular Oncology, Vol. 32, Núm. 4, pp. 275-283

2009

  1. Chromosomal changes in sporadic and familial head and neck paragangliomas

    Otolaryngology - Head and Neck Surgery, Vol. 140, Núm. 5, pp. 724-729